Pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, Company's Code of Conduct for Prevention of Insider Trading and BSE circular no. LIST/COMP/01/2019-20 dated April 2, 2019 regarding intimation for closure of Trading Window, Fermenta Biotech has informed that the ‘Trading Window’ i.e. period for trading in Company’s securities, will be closed with effect from January 01, 2025 till 48 hours after the declaration of financial results for the quarter and nine months ended December 31, 2024, as may be approved at the concerned Board Meeting. During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company’s equity shares, either in their own name or in the name of their immediate relatives. The intimation regarding the Board Meeting date will be announced in due course. Terms not defined in this notice shall have the same meaning as defined in the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |